We Can Help Your Medical Office
“We’ve got you covered”
Consultants to Increase Your Per Patient Revenues
Expedite Wound Closure With
Amniotic TISSUE
Use as protective wound barrier to providing an antimicrobial,
growth factor rich healing environment
Promotes native tissue repair by minimizing fibrosis, reducing inflammation,
and maximizing patient comfort
Expedite wound closure between 4-6 weeks on average.
Natural Biosynthetic Products
Treatment of Diabetic Ulcers, Venous Stasis Ulcer, Pressure Sores, Trauma Wounds and Burns
Expedited Wound Closure for Pain Reduction and Infection Control
A potential alternative to leg amputation, healing with native tissue and less scarring
Non-healing ulcer
Throughout treatment
Closure
Diabetic foot ulcer patients are twice as costly to US Medicare as those with diabetes alone.
The average cost of wound care is 10,000 - 20,000.
The average cost to lower limb amputation is 73,000 - 120,000.
A Powerful Regenerative Wound Matrix to Support Acute and Chronic Wound Closure
DermacyteTM products are derived from human postpartum amniotic tissues that have been processed to retain native extracellular matrix cytokines, growth factors, and collagen to support tissue remolding, improving patient outcomes and treatment comfort and are offered in a Liquid and Matrix form.
Easy to Use
Ready for Application
-
Dehydrated for easy application with no refrigeration
-
No preparation time required for thawing or soaking reducing operative time
Easy to Handle
-
Conforms to wound bed and naturally hydrates in place
-
Superior handling and optimal bioabsorption properties
Improved Patient Experience
Use as protective wound barrier to provide an antimicrobial, growth factor rich healing environment
Promotes native tissue repair by minimizing fibrosis, reducing inflammation, and maximizing patient comfort
Simple Wound Monitoring
Routine dressing changes, wound cleansing, and Dermacyte reapplication allows for easy assessment of wound closure.
Committed to Patient Safety
-
All tissues are recovered and processed by a U.S. FDA registered and AATB accredited tissue bank
-
A Licensed Medical Director confirms product eligibility through donor screening and testing records, and final culturing and sterility testing is confirmed prior to lot release
Clinical Applications
Dermacyte products are versatile coverings and void fillers that may be applied to various hard-to-heal wounds, including:
• Diabetic foot ulcers
• Venous stasis ulcers
• Burns
• Decubitus / Pressure Ulcers
• Surgical incisions
• Other dermal defects and wounds
Dermacyte
A Unique Bioactive Wound Covering
Scaffolds:
The special structure and biological viability of amniotic membrane is ideal in tissue engineering. The extracellular matrix components of the basement membrane creates a natural scaffold for cell attachment. 1
Signals:
Amniotic tissue is rich in cytokines, growth factors, and stem cells that play a role in improved healing and regeneration and decreased immunogenicity. 2
Cells:
Sufficient cues to allow for cell attachment and proliferation are properties of dehydrated amnion. Soluble factors secreted by human dermal fibroblasts cultured on amnion enhanced both endothelial cell and keratino- cyte survival and endothelial cell migration in a wound closure assay. 3
Product | Size |
|---|
